 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - LIGAND PHARMACEUTICALS INC
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-08-02 Purchase | 2019-08-05 7:04 pm | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Director | 1,000 | $93.59 | $93,594 | 49,474 (Direct) | View |
| 2019-08-05 Purchase | 2019-08-06 5:18 pm | LIGAND PHARMACEUTICALS INC | LGND | Aryeh Jason Director | 746 | $90.01 | $67,146 | 66,453 (Indirect Direct) | View |
| 2019-09-03 Purchase | 2019-09-03 7:34 pm | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E CFO | 500 | $86.18 | $43,091 | 17,151 (Direct) | View |
| 2019-09-03 Purchase | 2019-09-04 7:30 pm | LIGAND PHARMACEUTICALS INC | LGND | Aryeh Jason Director | 750 | $87.01 | $65,258 | 67,203 (Indirect Direct) | View |
| 2020-02-13 Sale | 2020-02-18 5:09 pm | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 7,225 | $95.84 | $692,467 | 156,229 (Direct) | View |
| 2020-02-27 Sale | 2020-02-27 8:35 pm | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 7,225 | $110 | $794,750 | 153,743 (Direct) | View |
| 2020-06-04 Sale | 2020-06-05 4:07 pm | LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP | 11,146 | $118.59 | $1,321,775 | 40,877 (Direct) | View |
| 2020-08-21 Sale | 2020-08-25 7:10 pm | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 7,303 | $112.86 | $824,190 | 155,413 (Direct) | View |
| 2020-08-25 Sale | 2020-08-27 7:06 pm | Viking Therapeutics Inc. | VKTX | LIGAND PHARMACEUTICALS INC 10% Owner | 164,488 | $8.0716 | $1,327,684 | 5,819,383 (Direct) | View |
| 2020-08-25 Sale(A) | 2020-08-28 5:11 pm | Viking Therapeutics Inc. | VKTX | LIGAND PHARMACEUTICALS INC 10% Owner | 148,700 | $8.108 | $1,205,660 | 5,819,383 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-08-05 Exercise | 2019-08-06 5:17 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP | 669 | $56.26 | 4,153 (Direct) | View |
| 2019-08-05 Exercise | 2019-08-06 5:17 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP | 424 | $85.79 | 4,153 (Direct) | View |
| 2019-08-05 Exercise | 2019-08-06 5:17 pm | N/A 2025-02-10 | LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP | 669 | $56.26 | 4,153 (Direct) | View |
| 2019-08-05 Exercise | 2019-08-06 5:17 pm | N/A 2026-02-11 | LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP | 424 | $85.79 | 4,153 (Direct) | View |
| 2019-08-12 Exercise | 2019-08-13 1:45 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 1,163 | $21.92 | 70,833 (Direct) | View |
| 2019-08-12 Exercise | 2019-08-13 1:45 pm | N/A 2023-02-15 | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 1,163 | $21.92 | 70,833 (Direct) | View |
| 2019-09-05 Exercise | 2019-09-05 7:24 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 1,005 | $21.92 | 69,828 (Direct) | View |
| 2019-09-05 Exercise | 2019-09-05 7:24 pm | N/A 2023-02-15 | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 1,005 | $21.92 | 69,828 (Direct) | View |
| 2019-09-19 Purchase | 2019-09-23 10:14 am | N/A 2023-05-15 | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 1,000,000 | $841,250 | 1,000,000 (Direct) | View |
| 2019-09-19 Purchase | 2019-09-23 10:14 am | N/A 2023-05-15 | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E CFO | 1,175,000 | $989,938 | 1,175,000 (Direct) | View |
| 2019-09-19 Purchase | 2019-09-24 7:11 pm | N/A 2023-05-15 | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 1,175,000 | $988,469 | 1,175,000 (Direct) | View |
| 2019-10-15 Option Award | 2019-10-16 6:01 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Boyce Sarah Director | 1,431 | $0 | 5,283 (Direct) | View |
| 2019-10-15 Option Award | 2019-10-16 6:01 pm | 2020-10-15 2029-10-15 | LIGAND PHARMACEUTICALS INC | LGND | Boyce Sarah Director | 5,283 | $107.81 | 5,283 (Direct) | View |
| 2019-11-12 Exercise | 2019-11-13 4:07 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 1,001 | $21.92 | 68,827 (Direct) | View |
| 2019-11-12 Exercise | 2019-11-13 4:07 pm | N/A 2023-02-15 | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 1,001 | $21.92 | 68,827 (Direct) | View |
| 2019-12-20 Option Award | 2019-12-26 2:00 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 7,668 | $0 | 153,614 (Direct) | View |
| 2019-12-20 Tax Withholding | 2019-12-26 2:00 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 3,801 | $105.87 | 153,614 (Direct) | View |
| 2019-12-20 Option Award | 2019-12-26 2:00 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 5,946 | $0 | 153,614 (Direct) | View |
| 2019-12-20 Tax Withholding | 2019-12-26 2:00 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 2,948 | $105.87 | 153,614 (Direct) | View |
| 2019-12-20 Option Award | 2019-12-26 2:01 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 4,458 | $0 | 148,337 (Direct) | View |
| 2019-12-20 Tax Withholding | 2019-12-26 2:01 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 2,210 | $105.87 | 148,337 (Direct) | View |
| 2019-12-20 Option Award | 2019-12-26 2:01 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 2,913 | $0 | 148,337 (Direct) | View |
| 2019-12-20 Tax Withholding | 2019-12-26 2:01 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 1,444 | $105.87 | 148,337 (Direct) | View |
| 2019-12-20 Option Award | 2019-12-26 2:01 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP | 1,693 | $0 | 49,069 (Direct) | View |
| 2019-12-20 Tax Withholding | 2019-12-26 2:01 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP | 585 | $105.87 | 49,069 (Direct) | View |
| 2019-12-20 Option Award | 2019-12-26 2:01 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP | 1,335 | $0 | 49,069 (Direct) | View |
| 2019-12-20 Tax Withholding | 2019-12-26 2:01 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP | 546 | $105.87 | 49,069 (Direct) | View |
| 2019-12-20 Option Award | 2019-12-26 2:01 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E CFO | 2,674 | $0 | 20,016 (Direct) | View |
| 2019-12-20 Tax Withholding | 2019-12-26 2:01 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E CFO | 1,135 | $105.87 | 20,016 (Direct) | View |
| 2019-12-20 Option Award | 2019-12-26 2:01 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E CFO | 2,305 | $0 | 20,016 (Direct) | View |
| 2019-12-20 Tax Withholding | 2019-12-26 2:01 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E CFO | 979 | $105.87 | 20,016 (Direct) | View |
| 2020-02-13 Option Award | 2020-02-18 5:05 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E CFO | 6,848 | $0 | 30,750 (Direct) | View |
| 2020-02-13 Option Award | 2020-02-18 5:05 pm | N/A 2030-02-13 | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E CFO | 30,750 | $95.68 | 30,750 (Direct) | View |
| 2020-02-13 Option Award | 2020-02-18 5:07 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP | 3,835 | $0 | 17,220 (Direct) | View |
| 2020-02-13 Tax Withholding | 2020-02-18 5:07 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP | 307 | $97.23 | 17,220 (Direct) | View |
| 2020-02-13 Tax Withholding | 2020-02-18 5:07 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP | 207 | $97.23 | 17,220 (Direct) | View |
| 2020-02-13 Tax Withholding | 2020-02-18 5:07 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP | 367 | $97.23 | 17,220 (Direct) | View |
| 2020-02-13 Option Award | 2020-02-18 5:07 pm | N/A 2030-02-13 | LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP | 17,220 | $95.68 | 17,220 (Direct) | View |
| 2020-02-13 Exercise | 2020-02-18 5:09 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 496 | $21.92 | 156,229 (Direct) | View |
| 2020-02-13 Option Award | 2020-02-18 5:09 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 7,396 | $0 | 156,229 (Direct) | View |
| 2020-02-13 Exercise | 2020-02-18 5:09 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 7,225 | $14.47 | 156,229 (Direct) | View |
| 2020-02-13 Tax Withholding | 2020-02-18 5:09 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 869 | $97.23 | 156,229 (Direct) | View |
| 2020-02-13 Tax Withholding | 2020-02-18 5:09 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 447 | $97.23 | 156,229 (Direct) | View |
| 2020-02-13 Tax Withholding | 2020-02-18 5:09 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 1,170 | $97.23 | 156,229 (Direct) | View |
| 2020-02-13 Exercise | 2020-02-18 5:09 pm | N/A 2022-02-09 | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 7,225 | $14.47 | 156,229 (Direct) | View |
| 2020-02-13 Exercise | 2020-02-18 5:09 pm | N/A 2023-02-15 | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 496 | $21.92 | 156,229 (Direct) | View |
| 2020-02-13 Option Award | 2020-02-18 5:09 pm | N/A 2030-02-13 | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 33,210 | $95.68 | 156,229 (Direct) | View |
| 2020-02-13 Exercise | 2020-02-18 5:11 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 48,125 | $9.96 | 0 (Direct) | View |
| 2020-02-13 Tax Withholding | 2020-02-18 5:11 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 5,009 | $95.68 | 0 (Direct) | View |
| 2020-02-13 Option Award | 2020-02-18 5:11 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 13,559 | $0 | 0 (Direct) | View |
| 2020-02-13 Tax Withholding | 2020-02-18 5:11 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 1,689 | $97.23 | 0 (Direct) | View |
| 2020-02-13 Tax Withholding | 2020-02-18 5:11 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 1,310 | $97.23 | 0 (Direct) | View |
| 2020-02-13 Tax Withholding | 2020-02-18 5:11 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 2,117 | $97.23 | 0 (Direct) | View |
| 2020-02-13 Option Award | 2020-02-18 5:11 pm | N/A 2030-02-13 | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 60,886 | $95.68 | 0 (Direct) | View |
| 2020-02-13 Exercise | 2020-02-18 5:11 pm | N/A 2020-02-15 | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 48,125 | $9.96 | 0 (Direct) | View |
| 2020-02-27 Exercise | 2020-02-27 8:35 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 7,225 | $14.47 | 153,743 (Direct) | View |
| 2020-02-27 Exercise | 2020-02-27 8:35 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 1,706 | $21.92 | 153,743 (Direct) | View |
| 2020-02-27 Exercise | 2020-02-27 8:35 pm | N/A 2022-02-09 | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 7,225 | $14.47 | 153,743 (Direct) | View |
| 2020-02-27 Exercise | 2020-02-27 8:35 pm | N/A 2023-02-15 | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 1,706 | $21.92 | 153,743 (Direct) | View |
| 2020-03-13 Exercise | 2020-03-13 6:33 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 2,000 | $21.92 | 64,625 (Direct) | View |
| 2020-03-13 Exercise | 2020-03-13 6:33 pm | N/A 2023-02-15 | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 2,000 | $21.92 | 64,625 (Direct) | View |
| 2019-02-15 Tax Withholding | 2020-04-24 7:22 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 1,918 | $120.86 | 133,982 (Direct) | View |
| 2019-02-15 Tax Withholding | 2020-04-24 7:22 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 1,689 | $120.86 | 133,982 (Direct) | View |
| 2019-02-15 Tax Withholding | 2020-04-24 7:22 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 1,310 | $120.86 | 133,982 (Direct) | View |
| 2019-02-15 Tax Withholding | 2020-04-24 7:23 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 938 | $120.86 | 122,727 (Direct) | View |
| 2019-02-15 Tax Withholding | 2020-04-24 7:23 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 1,246 | $120.86 | 122,727 (Direct) | View |
| 2019-02-15 Tax Withholding | 2020-04-24 7:23 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 642 | $120.86 | 122,727 (Direct) | View |
| 2019-02-15 Tax Withholding | 2020-04-24 7:24 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E CFO | 354 | $120.86 | 15,303 (Direct) | View |
| 2019-02-15 Tax Withholding | 2020-04-24 7:24 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E CFO | 377 | $120.86 | 15,303 (Direct) | View |
| 2019-02-15 Tax Withholding | 2020-04-24 7:24 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E CFO | 435 | $120.86 | 15,303 (Direct) | View |
| 2020-06-10 Option Award | 2020-06-12 6:32 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Patel Sunil Director | 831 | $0 | 2,468 (Direct) | View |
| 2020-06-10 Option Award | 2020-06-12 6:32 pm | N/A 2030-06-10 | LIGAND PHARMACEUTICALS INC | LGND | Patel Sunil Director | 2,468 | $117.58 | 2,468 (Direct) | View |
| 2020-06-10 Option Award | 2020-06-12 6:32 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | LAMATTINA JOHN L Director | 831 | $0 | 2,468 (Direct) | View |
| 2020-06-10 Option Award | 2020-06-12 6:32 pm | N/A 2030-06-10 | LIGAND PHARMACEUTICALS INC | LGND | LAMATTINA JOHN L Director | 2,468 | $117.58 | 2,468 (Direct) | View |
| 2020-06-10 Option Award | 2020-06-12 6:33 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director | 831 | $0 | 2,468 (Direct) | View |
| 2020-06-10 Option Award | 2020-06-12 6:33 pm | N/A 2030-06-10 | LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director | 2,468 | $117.58 | 2,468 (Direct) | View |
| 2020-06-10 Option Award | 2020-06-12 6:34 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Gray Nancy Ryan Director | 831 | $0 | 2,468 (Direct) | View |
| 2020-06-10 Option Award | 2020-06-12 6:34 pm | N/A 2030-06-10 | LIGAND PHARMACEUTICALS INC | LGND | Gray Nancy Ryan Director | 2,468 | $117.58 | 2,468 (Direct) | View |
| 2020-06-10 Option Award | 2020-06-12 6:34 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Director | 831 | $0 | 2,468 (Direct) | View |
| 2020-06-10 Option Award | 2020-06-12 6:34 pm | N/A 2030-06-10 | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Director | 2,468 | $117.58 | 2,468 (Direct) | View |
| 2020-06-10 Option Award | 2020-06-12 6:35 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Boyce Sarah Director | 831 | $0 | 2,468 (Direct) | View |
| 2020-06-10 Option Award | 2020-06-12 6:35 pm | N/A 2030-06-10 | LIGAND PHARMACEUTICALS INC | LGND | Boyce Sarah Director | 2,468 | $117.58 | 2,468 (Direct) | View |
| 2020-06-10 Option Award | 2020-06-12 6:35 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Aryeh Jason Director | 831 | $0 | 2,468 (Direct) | View |
| 2020-06-10 Option Award | 2020-06-12 6:35 pm | N/A 2030-06-10 | LIGAND PHARMACEUTICALS INC | LGND | Aryeh Jason Director | 2,468 | $117.58 | 2,468 (Direct) | View |
| 2020-06-10 Option Award | 2020-06-12 6:46 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L Director | 831 | $0 | 2,468 (Direct) | View |
| 2020-06-10 Option Award | 2020-06-12 6:46 pm | N/A 2030-06-10 | LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L Director | 2,468 | $117.58 | 2,468 (Direct) | View |
| 2020-06-30 Other | 2020-07-01 8:05 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E CFO | 238 | $89.03 | 25,936 (Direct) | View |
| 2020-06-30 Other | 2020-07-01 8:06 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP | 238 | $89.03 | 41,115 (Direct) | View |
| 2020-07-07 Exercise | 2020-07-09 4:28 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 1,165 | $85.79 | 54,226 (Direct) | View |
| 2020-07-07 Exercise | 2020-07-09 4:28 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 1,777 | $56.26 | 54,226 (Direct) | View |
| 2020-07-07 Exercise | 2020-07-09 4:28 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 1,373 | $74.42 | 54,226 (Direct) | View |
| 2020-07-07 Exercise | 2020-07-09 4:28 pm | N/A 2025-02-10 | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 1,777 | $56.26 | 54,226 (Direct) | View |
| 2020-07-07 Exercise | 2020-07-09 4:28 pm | N/A 2024-02-12 | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 1,373 | $74.42 | 54,226 (Direct) | View |
| 2020-07-07 Exercise | 2020-07-09 4:28 pm | N/A 2026-02-11 | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 1,165 | $85.79 | 54,226 (Direct) | View |
| 2020-08-21 Exercise | 2020-08-25 7:10 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 790 | $74.42 | 155,413 (Direct) | View |
| 2020-08-21 Exercise | 2020-08-25 7:10 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 7,225 | $14.47 | 155,413 (Direct) | View |
| 2020-08-21 Exercise | 2020-08-25 7:10 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 78 | $21.92 | 155,413 (Direct) | View |
| 2020-08-21 Exercise | 2020-08-25 7:10 pm | N/A 2022-02-09 | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 7,225 | $14.47 | 155,413 (Direct) | View |
| 2020-08-21 Exercise | 2020-08-25 7:10 pm | N/A 2023-02-15 | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 78 | $21.92 | 155,413 (Direct) | View |
| 2020-08-21 Exercise | 2020-08-25 7:10 pm | N/A 2024-02-12 | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 790 | $74.42 | 155,413 (Direct) | View |